OBJECTIVE: To estimate rates of recurrent tuberculosis due to reinfection and relapse, by HIV status, in a general population. DESIGN: Long-term cohort study in Karonga district, rural Malawi. METHODS: All tuberculosis patients with culture-proven disease in Karonga district were followed up after treatment. HIV testing was offered and all Mycobacterium tuberculosis isolates were fingerprinted using IS6110 RFLP. Fingerprints from initial and recurrent disease episodes were compared to distinguish relapse and reinfection: a second episode was considered a relapse if the fingerprint was identical or differed by only 1-4 bands and was the first occurrence of that pattern in the population. Rates of and risk factors for recurrence, reinfection disease, and relapse were estimated using survival analysis and Poisson regression. RESULTS: Five hundred and eighty-four culture-positive episodes of tuberculosis were diagnosed and treatment was completed during 1995-2003 in patients with known HIV status; 53 culture-positive recurrences occurred by May 2005. Paired fingerprints were available for 39 of these. Reinfections accounted for 1/16 recurrences in HIV-negative and 12/23 in HIV-positive individuals. Rates of relapse were similar in HIV-positive and HIV-negative individuals. Using multiple imputation to allow for missing fingerprint information, the rate of reinfection disease in HIV-positive individuals was 2.2/100 person-years, and in HIV-negative individuals 0.4/100 person-years. CONCLUSIONS: HIV increases the rate of recurrent tuberculosis in this setting by increasing the rate of reinfection disease, not relapse.
OBJECTIVE: To estimate rates of recurrent tuberculosis due to reinfection and relapse, by HIV status, in a general population. DESIGN: Long-term cohort study in Karonga district, rural Malawi. METHODS: All tuberculosis patients with culture-proven disease in Karonga district were followed up after treatment. HIV testing was offered and all Mycobacterium tuberculosis isolates were fingerprinted using IS6110 RFLP. Fingerprints from initial and recurrent disease episodes were compared to distinguish relapse and reinfection: a second episode was considered a relapse if the fingerprint was identical or differed by only 1-4 bands and was the first occurrence of that pattern in the population. Rates of and risk factors for recurrence, reinfection disease, and relapse were estimated using survival analysis and Poisson regression. RESULTS: Five hundred and eighty-four culture-positive episodes of tuberculosis were diagnosed and treatment was completed during 1995-2003 in patients with known HIV status; 53 culture-positive recurrences occurred by May 2005. Paired fingerprints were available for 39 of these. Reinfections accounted for 1/16 recurrences in HIV-negative and 12/23 in HIV-positive individuals. Rates of relapse were similar in HIV-positive and HIV-negative individuals. Using multiple imputation to allow for missing fingerprint information, the rate of reinfection disease in HIV-positive individuals was 2.2/100 person-years, and in HIV-negative individuals 0.4/100 person-years. CONCLUSIONS: HIV increases the rate of recurrent tuberculosis in this setting by increasing the rate of reinfection disease, not relapse.
Authors: Suzanne Verver; Robin M Warren; Nulda Beyers; Madalene Richardson; Gian D van der Spuy; Martien W Borgdorff; Donald A Enarson; Marcel A Behr; Paul D van Helden Journal: Am J Respir Crit Care Med Date: 2005-04-14 Impact factor: 21.405
Authors: R M Warren; G D van der Spuy; M Richardson; N Beyers; M W Borgdorff; M A Behr; P D van Helden Journal: J Clin Microbiol Date: 2002-05 Impact factor: 5.948
Authors: J L Johnson; A Okwera; M J Vjecha; F Byekwaso; J Nakibali; S Nyole; J Milberg; T Aisu; C C Whalen; R D Mugerwa; J J Ellner Journal: Int J Tuberc Lung Dis Date: 1997-10 Impact factor: 2.373
Authors: A S de Boer; M W Borgdorff; P E de Haas; N J Nagelkerke; J D van Embden; D van Soolingen Journal: J Infect Dis Date: 1999-10 Impact factor: 5.226
Authors: Judith R Glynn; Malcolm D Yates; Amelia C Crampin; Bagrey M Ngwira; Frank D Mwaungulu; Gillian F Black; Steven D Chaguluka; Donex T Mwafulirwa; Sian Floyd; Caroline Murphy; Francis A Drobniewski; Paul E M Fine Journal: J Infect Dis Date: 2004-08-03 Impact factor: 5.226
Authors: Amelia C Crampin; Judith R Glynn; Bagrey M Ngwira; Frank D Mwaungulu; Jörg M Pönnighaus; David K Warndorff; Paul E Fine Journal: AIDS Date: 2003-08-15 Impact factor: 4.177
Authors: Robin M Warren; Thomas C Victor; Elizabeth M Streicher; Madalene Richardson; Nulda Beyers; Nicolaas C Gey van Pittius; Paul D van Helden Journal: Am J Respir Crit Care Med Date: 2003-12-30 Impact factor: 21.405
Authors: Isdore C Shamputa; Levan Jugheli; Nikoloz Sadradze; Eve Willery; Françoise Portaels; Philip Supply; Leen Rigouts Journal: Respir Res Date: 2006-07-17
Authors: Judith R Glynn; Amelia C Crampin; Hamidou Traore; Malcolm D Yates; Frank D Mwaungulu; Bagrey M Ngwira; Steven D Chaguluka; Donex T Mwafulirwa; Sian Floyd; Caroline Murphy; Francis A Drobniewski; Paul E M Fine Journal: Emerg Infect Dis Date: 2005-01 Impact factor: 6.883
Authors: M Gabriela M Gomes; Ricardo Aguas; João S Lopes; Marta C Nunes; Carlota Rebelo; Paula Rodrigues; Claudio J Struchiner Journal: Proc Biol Sci Date: 2012-02-22 Impact factor: 5.349
Authors: Munyaradzi Dimairo; Peter MacPherson; Tsitsi Bandason; Abbas Zezai; Shungu S Munyati; Anthony E Butterworth; Stanley Mungofa; Simba Rusikaniko; Katherine Fielding; Peter R Mason; Elizabeth L Corbett Journal: PLoS One Date: 2010-07-28 Impact factor: 3.240
Authors: Ifedayo M O Adetifa; Martin O C Ota; Brigitte Walther; Abdulrahman S Hammond; Moses D Lugos; David J Jeffries; Simon A Donkor; Richard A Adegbola; Philip C Hill Journal: PLoS One Date: 2010-09-01 Impact factor: 3.240